Zobrazeno 1 - 10
of 363
pro vyhledávání: '"Chun Qiao"'
Autor:
Mengya Zhao, Beiying Dai, Xiaodong Li, Yixin Zhang, Chun Qiao, Yaru Qin, Zhao Li, Qingmei Li, Shuzhen Wang, Yong Yang, Yijun Chen
Publikováno v:
eLife, Vol 12 (2024)
Philadelphia chromosome-positive (Ph+) leukemia is a fatal hematological malignancy. Although standard treatments with tyrosine kinase inhibitors (TKIs) have achieved remarkable success in prolonging patient survival, intolerance, relapse, and TKI re
Externí odkaz:
https://doaj.org/article/e37ea5e03f2b4c1590e63e874d6ee52f
Autor:
Hui Yang, Yueming Gong, Yawen Zhang, Xinyu Zhang, Yue LI, Ting Zhang, Qiqiang Long, Chun Qiao, Guangsheng He, Jianyong LI
Publikováno v:
HemaSphere, Vol 7, p e766351e (2023)
Externí odkaz:
https://doaj.org/article/d3e7501dc65a40bf82a6843935804330
Autor:
Luqiao Wang, Zijuan Wu, Yi Xia, Xueying Lu, Ji Li, Lei Fan, Chun Qiao, Hairong Qiu, Danling Gu, Wei Xu, Jianyong Li, Hui Jin
Publikováno v:
Clinical and Translational Medicine, Vol 12, Iss 5, Pp n/a-n/a (2022)
Abstract Background Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma. Histone deacetylase inhibitors (HDACis) have been widely applied in multiple tumours, but the expected efficacy was not observed in DLBC
Externí odkaz:
https://doaj.org/article/6e11263b717f446288de34e24f57fbf5
Autor:
Si-Si Chen, Qian Sun, Lan Cao, Wen-Zhong Wu, Yue Xie, Chun Qiao, Jian-Yong Li, Si-Xuan Qian, Ming Hong, Peng Lyu.
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 12, Pp 1477-1479 (2021)
Externí odkaz:
https://doaj.org/article/b1a5f2736a6b49cb9b25bba4805be9dc
Autor:
Ke Shi, Qian Sun, Chun Qiao, Huayuan Zhu, Li Wang, Jiazhu Wu, Lili Wang, Jianxin Fu, Ken H. Young, Lei Fan, Yi Xia, Wei Xu, Jianyong Li
Publikováno v:
Cancer Medicine, Vol 9, Iss 3, Pp 999-1007 (2020)
Abstract Immunoglobulin heavy chain variable region (IGHV) mutational status has been an important prognostic factor for chronic lymphocytic leukemia (CLL) for decades. Patients with unmutated IGHV (≥98% identity to the germline sequence) have infe
Externí odkaz:
https://doaj.org/article/748ea71550bf4daf8d0eb725645e4b4e
Autor:
Yi-Xin Zou, Han-Ning Tang, Jing Zhang, Xiao-Lu Tang, Shu-Chao Qin, Yi Xia, Hua-Yuan Zhu, Chun Qiao, Li Wang, Lei Fan, Wei Xu, Jian-Yong Li, Yi Miao
Publikováno v:
Translational Oncology, Vol 14, Iss 10, Pp 101176- (2021)
The 11q deletion (del(11q)) is a conventional cytogenetic aberration observed in chronic lymphocytic leukemia (CLL) patients. However, the prevalence and the prognostic value of del(11q) are still controversial. In this research, we retrospectively e
Externí odkaz:
https://doaj.org/article/6a10ef5d4b1b46a5b6dad3fc1e010142
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Background: γδT cell lymphoma (γδ TCL) is a class of hematopoietic malignancy that expresses the γδ T cell receptor (TCR) with a low incidence. Determining the clonal proliferation of γδT cells is important for the diagnosis of such malignanc
Externí odkaz:
https://doaj.org/article/0a72165951e045cb925ec3272718e047
Autor:
Zi-Qing-Yun Yuan, Chun Qiao, Zhi-Cheng Yang, Lei Yu, Lu-Ning Sun, Yi Qian, Xue-Hui Zhang, Ling Meng, Xiao-Yan Zhang, Yong-Qing Wang
Publikováno v:
Frontiers in Pharmacology, Vol 11 (2020)
This study investigated voriconazole (VRC) unbound plasma concentration and its relationship with adverse drug reactions (ADRs) in patients with malignant hematologic disease. Plasma samples were collected from patients or spiked in vitro. A time-sav
Externí odkaz:
https://doaj.org/article/0d7283cbc21148ea92841194fba8efbe
Autor:
Yixin Zou, Lei Fan, Yi Xia, Yi Miao, Wei Wu, Lei Cao, Jiazhu Wu, Huayuan Zhu, Chun Qiao, Li Wang, Wei Xu, Jianyong Li
Publikováno v:
Cancer Medicine, Vol 7, Iss 5, Pp 1689-1696 (2018)
Abstract The proto‐oncogene NOTCH1 is frequently mutated in around 10% of patients with chronic lymphocytic leukemia (CLL). This study analyzed NOTCH1 mutation status of 317 Chinese patients with CLL by Sanger sequencing. The frequencies of NOTCH1
Externí odkaz:
https://doaj.org/article/4486cb12b3dd4c449fd07797544fe14c
Autor:
Yi Miao, Hua-Yuan Zhu, Chun Qiao, Yi Xia, Yiling Kong, Yi-Xin Zou, Yu-Qing Miao, Xiao Chen, Lei Cao, Wei Wu, Jin-Hua Liang, Jia-Zhu Wu, Li Wang, Lei Fan, Wei Xu, Jian-Yong Li
Publikováno v:
Frontiers in Immunology, Vol 10 (2019)
Hemophagocytic lymphohistiocytosis (HLH) can be classified into primary HLH and secondary HLH. Primary HLH usually occurs in infants and children with an underlying genetic defect, and there are also teens and occasional adults with primary HLH. Most
Externí odkaz:
https://doaj.org/article/b46ad6d64257456ca43b40e6981e8d79